Intensive Care Unit Conflict Mediation Study ("GIRAFFE")

June 1, 2026 updated by: Hospital Israelita Albert Einstein

A Multidisciplinary Framework for ICU Conflict Mediation: Rationale and Methodological Approach to Enhancing Safety and Care Quality

To evaluate the impact of a structured, multidisciplinary conflict management program incorporating an interprofessional Singular Care Plan *PAS* Committee and a Conflict Mediation Team on the incidence and severity of conflicts, family satisfaction, and staff well-being in an adult intensive care unit *ICU*

Study Overview

Status

Not yet recruiting

Intervention / Treatment

Detailed Description

The allocation is non randomized because the intervention is implemented at the level of the intensive care unit and cannot ethically or practically be restricted to a subset of patients or staff. The masking status is open label, as it is not feasible to blind staff or families to the presence of a conflict mediator or the convening of a committee. The primary purpose of the study is health services research, specifically the evaluation of an institutional policy for conflict management and its impact on conflict dynamics, safety and experience in critical care.

Study Type

Interventional

Enrollment (Estimated)

100

Phase

  • Not Applicable

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

  • Adult
  • Older Adult

Accepts Healthy Volunteers

Yes

Description

-family members of patients or intensive care unit staff

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Supportive Care
  • Allocation: N/A
  • Interventional Model: Single Group Assignment
  • Masking: None (Open Label)

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
Experimental: Structured Conflict Management Program
All participants will be part of a single arm titled "Structured Conflict Management Program". The intervention is an organizational and behavioral program that introduces a Conflict Mediation Team and a Singular Care Plan Committee in the intensive care unit, grounded in nonviolent communication. The Conflict Mediation Team is composed of trained facilitators who can be activated by any assistential collaborator when a conflict in progress exceeds the collaborator's capacity to manage it. The Singular Care Plan Committee is convened by the facilitator in complex cases that require broader, interprofessional analysis and the elaboration of a documented care plan based on the SEM DESTINO mnemonic.
The Conflict Mediation Team is composed of trained facilitators who can be activated by any assistential collaborator when a conflict in progress exceeds the collaborator's capacity to manage it. The Singular Care Plan Committee is convened by the facilitator in complex cases that require broader, interprofessional analysis and the elaboration of a documented care plan based on the SEM DESTINO mnemonic

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
-conflict index
Time Frame: 12 months
the rate of significant conflicts per 100 ICU admissions.
12 months
Prevalence of post-traumatic stress symptoms in ICU family member
Time Frame: 6 months after ICU discharge
Proportion of ICU family members with post-traumatic stress symptoms, defined as an Impact of Event Scale-6 (IES-6) mean item score > 1.75, assessed 6 months after ICU discharge of the index patient.
6 months after ICU discharge

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Estimated)

October 1, 2026

Primary Completion (Estimated)

August 1, 2027

Study Completion (Estimated)

August 1, 2027

Study Registration Dates

First Submitted

May 18, 2026

First Submitted That Met QC Criteria

June 1, 2026

First Posted (Actual)

June 2, 2026

Study Record Updates

Last Update Posted (Actual)

June 2, 2026

Last Update Submitted That Met QC Criteria

June 1, 2026

Last Verified

May 1, 2026

More Information

Terms related to this study

Other Study ID Numbers

  • 68567898809090

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

NO

IPD Plan Description

sensible data HIPPA ACT

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Aggression

Clinical Trials on SEM DESTINO

Subscribe